CCL2 and diabetic neuropathy: With the progression of diabetic neuropathy, there is an increase in the concentrations of monocyte chemotactic protein 1 (MCP-1), angiotensinogen (AGT), and liver-type fatty acid-binding protein (L-FABP) [6,7,8,9].